Methuselah

Methuselah (玛士撒拉) is a Chinese medical-nutrition food brand positioned at the intersection of elder care and chronic-disease management, with FreeS Fund as its core backer. Per FreeS Fund's reporting, the company has built a rare full-spectrum product line spanning special medical foods, low-GI foods, and energy-control weight-management products, and as of early 2024 had entered more than 700 tertiary hospitals and served over 10 million patients . FreeS Fund led Methuselah's angel and Series A rounds, participated in its A+ rounds, and continued to follow on through its Series B and B+ rounds in 2025 . The firm frames Methuselah as a representative brand in the professionalization and technology upgrade wave of China's food industry, riding the anticipated boom in senior consumption between 2025 and 2030 .